Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

An Open Label, Randomized Controlled Trial to Establish the Efficacy and Safety of a Study Strategy Consisting of 6 Months of Bedaquiline (BDQ), Delamanid (DLM), and Linezolid (LNZ), With Levofloxacin (LVX) and Clofazimine (CFZ) Compared to the Current South African Standard of Care (Control Strategy) for 9 Months for the Treatment of Rifampicin Resistant Tuberculosis (RR-TB)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04062201
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:26:14.896514+00:00
Published At
2024-08-28T00:00:00+00:00
Record Updated At
2024-08-28
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Tuberculosis", "Pre-XDR-TB", "Extensively Drug-Resistant Tuberculosis", "Multi Drug Resistant Tuberculosis", "Rifampicin Resistant Tuberculosis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-08-28"
protocolSection.identificationModule.nctId
"NCT04062201"
protocolSection.identificationModule.officialTitle
"An Open Label, Randomized Controlled Trial to Establish the Efficacy and Safety of a Study Strategy Consisting of 6 Months of Bedaquiline (BDQ), Delamanid (DLM), and Linezolid (LNZ), With Levofloxacin (LVX) and Clofazimine (CFZ) Compared to the Current South African Standard of Care (Control Strategy) for 9 Months for the Treatment of Rifampicin Resistant Tuberculosis (RR-TB)"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Tuberculosis (protocolSection.conditionsModule.conditions)
  • Pre-XDR-TB (protocolSection.conditionsModule.conditions)
  • Extensively Drug-Resistant Tuberculosis (protocolSection.conditionsModule.conditions)
  • Multi Drug Resistant Tuberculosis (protocolSection.conditionsModule.conditions)
  • Rifampicin Resistant Tuberculosis (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.